Aralyst
Ended Awarded Last action
- Contract number
- 36C26024F0335
- Awardee
-
Kiniksa Pharmaceuticals (Uk), LTD. UEI HBHWNLNMHSV5
- Awarding agency
-
Veterans Integrated Service Network 20
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $143,887
Award facts
- Contract value 100% obligated
- $143,886.87 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- La Vergne, TN 37086, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | -$48,280 | |
| Funding Only Action | $1,336 | |
| Other Administrative Action | $0 | |
| Original award | $190,832 |
About this award
This federal contract award is for Delivery Order 36F79722D0002|36C26024F0335, issued by the Department of Veterans Affairs (VA) Veterans Integrated Service Network 20 (VISN 20) to Kiniksa Pharmaceuticals (UK), LTD. The $143,886.87 firm fixed-price contract is for the pharmaceutical product Arcalyst (Rilonacept), a medication used to treat chronic inflammatory disorders. This delivery order is part of a larger $5.9 million Blanket Purchase Agreement (BPA) held by Kiniksa with the VA National Acquisition Center, as well as a $700,000 Federal Supply Schedule contract under the GSA Pharmaceuticals and Drugs schedule. The contract has an ultimate completion date of April 3, 2025 and does not utilize any set-aside designations, indicating open competition. Kiniksa Pharmaceuticals is a foreign-owned, for-profit biopharmaceutical company based in the United Kingdom that specializes in providing pharmaceutical products to federal government agencies, particularly the VA and Department of Justice.
Quick answers
Who was awarded contract 36C26024F0335?
36C26024F0335 was awarded to Kiniksa Pharmaceuticals (Uk), LTD. by Veterans Integrated Service Network 20 (Veterans Health Administration) on April 3, 2024.
How much is contract 36C26024F0335 worth?
The government has obligated $143,887 on 36C26024F0335.
Is contract 36C26024F0335 an order under another contract?
Yes. 36C26024F0335 is a delivery order under 36F79722D0002, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36C26024F0335 competed?
The extent of competition for 36C26024F0335 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award